reports
Quanterix Releases Operating Results for Third Quarter 202
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the three months ended September 30, 2023. Third Quarter Financial Highlights Revenue was $31.3 million, an 18% increase from $26.6 million for the corresponding prior year period. GAAP gross margin was 56.8% as compared to 41.1% for the corresponding prior year period. Non-GAAP gross margin was 48.6% as compared to 34.9% for the corresponding prior year period. Net loss was $7.8 million as compared to $35.1 mill...
- Jonathan Moreland
VGR VECTOR GROUP LTD.
SWX SOUTHWEST GAS HOLDINGS INC.
SMLR SEMLER SCIENTIFC
SEE SEALED AIR CORPORATION
PSEC PROSPECT CAPITAL CORPORATION
MGNX MACROGENICS INC.
GME GAMESTOP CORP. CLASS A
GABC GERMAN AMERICAN BANCORP
FIVE FIVE BELOW INC.
CNTY CENTURY CASINOS INC.
CDXS CODEXIS
ALDX ALDEYRA THERAPEUTICS
OFIX ORTHOFIX INTERNATIONAL N.V.
VIRT VIRTU FINANCIAL INC. CLASS A
SHW SHERWIN-WILLIAMS COMPANY
CULP CULP INC.
FMC FMC CORPORATION
UEIC UNIVERSAL ELECTRONICS INC.
GHC GRAHAM HOLDINGS CO.
SMMF SUMMIT FINANCIAL GROUP INC.
FLWS 1-800-FLOWERS.COM CL A
BRID BRIDGFORD FOODS CORP.
IOVA IOVANCE BIOTHERAPEUTICS INC
FNKO FUNKO CLASS A
QTRX QUANTERIX CORPORATION
QNTO QUAINT OAK BANCORP INC.
ATXI AVENUE THERAPEUTICS
HURC HURCO COMPANIES
EML THE EASTERN COMPANY
VAPO VAPOTHERM INC
JYNT THE JOINT
ASAN ASANA
PVBC PROVIDENT BANCORP INC
MODV MODIVCARE INC
NRGX PIMCO ENERGY & TACTICAL CREDIT OPPORTUNITIES FUND
AKYA AKOYA BIOSCIENCES INC
TSE TRINSEO PLC
MPA BLACKROCK MUNIYIELD PENNSYLVANIA FD
EMO CLEARBRIDGE ENERGY MLP OPPORTUNITY FUND INC.
SOL RENESOLA LTD
GATO SUNSHINE SILVER MINING AND REFINING CORP
- Jonathan Moreland
SEE SEALED AIR CORPORATION
MGNX MACROGENICS INC.
GME GAMESTOP CORP. CLASS A
BECN BEACON ROOFING SUPPLY INC.
ALDX ALDEYRA THERAPEUTICS
SHW SHERWIN-WILLIAMS COMPANY
CULP CULP INC.
FLL FULL HOUSE RESORTS INC.
FLWS
FNKO 1-800-FLOWERS.COM CL A
QTRX FUNKO CLASS A
VAPO QUANTERIX CORPORATION
MODV VAPOTHERM INC
NRGX MODIVCARE INC
AKYA PIMCO ENERGY & TACTICAL CREDIT OPPORTUNITIES FUND
MPA AKOYA BIOSCIENCES INC
EMO BLACKROCK MUNIYIELD PENNSYLVANIA FD
SOL CLEARBRIDGE ENERGY MLP OPPORTUNITY FUND INC.
RENESOLA LTD
Quanterix Corp: 1 director
A director at Quanterix Corp bought 20,200 shares at 24.850USD and the significance rating of the trade was 98/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
- Jonathan Moreland
BLUE BLUEBIRD BIO INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
RCKY ROCKY BRANDS
PRTK PARATEK PHARMACEUTICALS INC
HUN HUNTSMAN CORPORATION
HCI HCI GROUP INC.
HASI HANNON ARMSTRONG SUSTAINABLE INFRASTRUCTURE CAPITAL INC.
ECL ECOLAB INC.
DISH DISH NETWORK CORPORATION CLASS A
CLMT CALUMET SPECIALTY PRODUCTS PARTNERS L.P.
BXP BOSTON PROPERTIES INC.
DGICA DONEGAL GROUP INC. CL A
ET ENERGY TRANSFER L.P.
NR NEWPARK RESOURCES INC.
TWLO TWILIO INC. CLASS A
OCX ONCOCYTE
CLF CLIFFS NATURAL RESOURCES INC.
RBBN RIBBON COMMUNICATIONS
QTRX QUANTERIX CORPORATION
FLNT FLUENT INC
GIM TEMPLETON GLOBAL INCOME FUND
SAVA CASSAVA SCIENCES
ZM ZOOM VIDEO COMMUNICATIONS
TELA INC.
VOXX TELA BIO
RPRX AUDIOVOX CORPORATION
CERE ROYALTY PHARMA PLC CLASS A
PRCH CEREVEL THERAPEUTICS HOLDINGS (A)
CMPX PORCH GROUP INC (A)
TERN COMPASS THERAPEUTICS
PATH INC.
SMMT TERNS PHARMACEUTICALS
SQSP UIPATH
WISH INC.
INAB SUMMIT THERAPEUTICS INC
RKT SQUARESPACE
TRIN INC.
BARK CONTEXTLOGIC INC.
MDRR IN8BIO INC
UAVS ROCKET SHARING COMPANY SPA
TRINITY EXPLORATION & PRODUCTION
ORIGINAL BARK CO
MEDALIST DIVERSIFIED REIT INC
AGEAGLE AERIAL SYSTEMS
- Jonathan Moreland
HASI HANNON ARMSTRONG SUSTAINABLE INFRASTRUCTURE CAPITAL INC.
BXP BOSTON PROPERTIES INC.
DGICA DONEGAL GROUP INC. CL A
KELYA KELLY SERVICES INC. CLASS A
PBI PITNEY BOWES INC.
TWLO TWILIO INC. CLASS A
RBBN RIBBON COMMUNICATIONS
QTRX QUANTERIX CORPORATION
FLNT FLUENT INC
CSPI CSP INC.
GIM TEMPLETON GLOBAL INCOME FUND
SAVA CASSAVA SCIENCES
ZM ZOOM VIDEO COMMUNICATIONS
TELA INC.
VOXX TELA BIO
PRCH AUDIOVOX CORPORATION
TERN PORCH GROUP INC (A)
PATH TERNS PHARMACEUTICALS
HLLY UIPATH
WISH INC.
TMC HOLLEY INC.
CONTEXTLOGIC INC.
TMC THE METALS CO INC
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
WCC WESCO INTERNATIONAL INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
PKOH PARK-OHIO HOLDINGS CORP.
PBPB POTBELLY CORP.
OPK OPKO HEALTH INC.
NEOG NEOGEN CORPORATION
LXRX LEXICON PHARMACEUTICALS INC.
KMPR KEMPER CORPORATION
CRK COMSTOCK RESOURCES INC.
COMM COMMSCOPE HOLDING CO. INC.
CLMT CALUMET SPECIALTY PRODUCTS PARTNERS L.P.
AZZ AZZ INC.
ALDX ALDEYRA THERAPEUTICS
AAT AMERICAN ASSETS TRUST INC.
DGICA DONEGAL GROUP INC. CL A
CNFR CONIFER HOLDINGS
ET ENERGY TRANSFER L.P.
UNVR UNIVAR SOLUTIONS INC.
BSM BLACK STONE MINERALS LP
XOM EXXON MOBIL CORPORATION
JELD JELD-WEN HOLDING INC.
VST VISTRA CORP.
QTRX QUANTERIX CORPORATION
TDW TIDEWATER INC
GIM TEMPLETON GLOBAL INCOME FUND
OPBK OP BANCORP
HCAT HEALTH CATALYST
PSN PARSONS
TELA TELA BIO
GCI GANNETT CO. INC.
VOXX AUDIOVOX CORPORATION
TSLX SIXTH STREET SPECIALTY LENDING
RPRX INC.
IHRT ROYALTY PHARMA PLC CLASS A
PACK IHEARTMEDIA INC. CLASS A
RSVR RANPAK HOLDINGS (A)
TRIN RESERVOIR MEDIA
ECVT INC.
RKT TRINITY CAPITAL INC
MDRR ECOVYST INC
SONM ROCKET SHARING COMPANY SPA
MEDALIST DIVERSIFIED REIT INC
SONIM TECHNOLOGIES INC
- Jonathan Moreland
PBPB POTBELLY CORP.
COMM COMMSCOPE HOLDING CO. INC.
ALDX ALDEYRA THERAPEUTICS
ET ENERGY TRANSFER L.P.
WINA WINMARK CORP.
VST VISTRA CORP.
QTRX QUANTERIX CORPORATION
TDW TIDEWATER INC
GIM TEMPLETON GLOBAL INCOME FUND
OPBK OP BANCORP
VOXX AUDIOVOX CORPORATION
RPRX ROYALTY PHARMA PLC CLASS A
LDI LOANDEPOT
RSVR RESERVOIR MEDIA
INC.
- Jonathan Moreland
NEOG NEOGEN CORPORATION
CLMT CALUMET SPECIALTY PRODUCTS PARTNERS L.P.
AZZ AZZ INC.
ALDX ALDEYRA THERAPEUTICS
AAT AMERICAN ASSETS TRUST INC.
DGICA DONEGAL GROUP INC. CL A
ET ENERGY TRANSFER L.P.
UNVR UNIVAR SOLUTIONS INC.
QTRX QUANTERIX CORPORATION
GIM TEMPLETON GLOBAL INCOME FUND
ZM ZOOM VIDEO COMMUNICATIONS
NREF INC.
VOXX NEXPOINT REAL ESTATE FINANCE
TSLX INC.
IHRT AUDIOVOX CORPORATION
CMPX SIXTH STREET SPECIALTY LENDING
LFST INC.
RKT IHEARTMEDIA INC. CLASS A
TRIN COMPASS THERAPEUTICS
SONM INC.
LIFESTANCE HEALTH GROUP
INC.
ROCKET SHARING COMPANY SPA
TRINITY EXPLORATION & PRODUCTION
SONIM TECHNOLOGIES INC
Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Re...
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that Eli Lilly and Company, a global healthcare company, presented new data from Lilly’s Phase 2 TRAILBLAZER-ALZ study at AAIC 2021 utilizing Quanterix’ highly sensitive Simoa® technology. The study utilized Quanterix’ HD-X technology and assays to measure P-tau217 (tau phosphorylated at threonine 217), using antibodies developed by Lilly. Lilly reported that the data demonstrates a significant reduction in blood levels of pho...
Quanterix Corporation to Release Second Quarter 2021 Financial Results...
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its financial results for second quarter 2021 after the close of trading on Aug. 5, 2021. Company management will host a conference call at 4:30pm ET to discuss Quanterix’ financial results and provide a business update. The call will be hosted by Kevin Hrusovsky, Chairman and Chief Executive Officer, Quanterix. Individuals interested in listening to the conference call may do so by dialing 833-686-9351 for domestic calle...
Quanterix’ Simoa Technology Powers Largest and Most Diverse Global Inv...
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its has been used in a worldwide collaborative study of the plasma neurofilament light (NfL) biomarker to evaluate its utility for a range of neurological conditions. Published in , the research marks the most robust effort to date assessing the use of NfL in blood to screen for neurodegeneration as a cause of cognitive symptoms; differentiate among neurodegenerative disorders and distinguish psychiatric disorders; and de...
Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman S...
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chairman and Chief Executive Officer, Quanterix, Kevin Hrusovsky will be delivering a virtual presentation at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10th at 3:50pm ET. Attendees can access the public webcast at or by visiting the News & Events page within the Investors section of the Quanterix website at . Replays of the webcast will be available on the Quanterix website for 90 days following the conference. ...
Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnos...
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced it has named Masoud Toloue to the position of President of Quanterix and Diagnostics, effective June 9, 2021. “We are excited to welcome Masoud to our team at such an important moment for Quanterix,” said Kevin Hrusovsky, Chairman and Chief Executive Officer Quanterix. “We are making important strides in advancing our diagnostic capability and assays, given the NIH RADx funding, our COVID-19 Emergency Use Authorizat...
Quanterix Corporation Releases Operating Results for First Quarter 202...
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ: QTRX), a company helping to transform healthcare with digital protein biomarker technology enabling precision health, today announced financial results for the three months ending March 31, 2021. “We made productive advances on our strategic and operational priorities during the first quarter 2021,” said Chairman, Chief Executive Officer and President, Quanterix, Kevin Hrusovsky. “The precision health ecosystem continues to catalyze interest and adoption from healthcare payors, government agencies, academia, and pharmaceutical companies as they ma...
Quanterix Corporation to Release First Quarter 2021 Financial Results ...
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that it will release its financial results for first quarter 2021 after the close of trading on Wednesday, May 5, 2021. Company management will host a conference call at 4:30 p.m., ET to discuss Quanterix’ financial results and provide a business update. The call will be hosted by Kevin Hrusovsky, Chairman and Chief Executive Officer, Quanterix. Individuals interested in listening to the conference call may do so by dialing (800) 697-5978 for...
Quanterix Appoints Laurie Olson to Board of Directors
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced the appointment of Laurie Olson to its Board of Directors, effective April 27, 2021. Olson is a seasoned pharmaceutical executive who brings more than three decades of experience in commercial and corporate strategy from Pfizer, Inc. to the Quanterix Board. She most recently served as executive vice president, strategy and commercial operations at Pfizer until 2018, where she led a team of approximately 2,000 people across 100...
Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers...
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced a webinar with leading industry experts to discuss neurological advancements related to the ultra-sensitive quantification of pTau181, pTau217, pTau231, and other neurological biomarkers. With several pharmaceutical companies making significant advances towards approval of Alzheimer's Disease therapies, this webinar discussion and live Q and A will further show the opportunity for blood plasma biomarkers combined with Simoa® technology to help ...
Quanterix Announces Appointment of Interim Chief Financial Officer
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it has appointed Shawn Stetson as the Company's interim chief financial officer, effective May 11, 2021. Mr. Stetson will assume his new responsibilities upon the departure of the Company’s current chief financial officer Amol Chaubal, who has accepted the chief financial officer role at Waters Corporation. Quanterix has initiated a search for a permanent replacement. Kevin Hrusovsky, Chairman, Chief Executive Officer, an...
Quanterix’ Simoa Technology Demonstrates Advancements in COVID-19 Rese...
BILLERICA, Mass.--(BUSINESS WIRE)-- (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its has been used in research studies to detect the SARS-CoV-2 virus in serum/plasma, dried blood microsamples (DBS) and saliva samples obtained from polymerase chain reaction (PCR)+ COVID-19 patients. Published in , the research study of these technologies offers further evidence that non-invasive antigen detection in blood or saliva samples, including from asymptomatic and pre-symptomatic individuals, can serve as an important complemen...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.